Skip to content

Clinical trials

Phase 2 Lung Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 2 Country / region: Spain Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20131
20151
20181
20201
20214
20231
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundación GECP4
Pfizer3
Upstream Bio Inc.2
Cardeas Pharma1
Debiopharm International SA1
Iovance Biotherapeutics, Inc.1
Mereo BioPharma1
OncoMed Pharmaceuticals, Inc.1
Pulmovant, Inc.1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases18
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms6
Respiratory Tract Diseases6
Carcinoma5
Asthma4
Respiratory Tract Neoplasms4
Bronchial Diseases3
Bronchial Neoplasms3
Thoracic Neoplasms3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.